FDA Official Who Scrutinized COVID Shots, Antidepressants Is Out in Latest Shake-Up
An FDA official involved in scrutinizing the safety of antidepressants, COVID-19 vaccines, and other widely used therapies has been removed from her role leading the agency’s drug program. Tracy Beth Hoeg, MD, PhD, will be replaced as FDA acting drug center director by Mike Davis, MD, PhD, who has been serving as deputy director, according…
